Retour aux projets

25776.1 PFLS-LS

Identification of tumor antigens in cancer patients by a novel technology

Résumé

Identification of tumor antigens in cancer patients by a novel technology

Textes supplémentaires

Abstract

Vaccination against cancer is a promising therapeutic approach. Unfortunately, tumor antigens recognized by the immune system remain largely unknown. We have established a novel technology that allows fast and effective identification of such antigens recognized by tumor infiltrating T cells of individual patients. This knowledge provides the basis for development of efficient personalized cancer vaccines. We have verified our technology in various mouse models. With this project we will make the first step towards taking in to the clinics.

Participants

Manfred Kopf

Kontaktperson

manfred.kopf@biol.ethz.ch

ETH Zürich Manfred Kopf Otto-Stern-weg 7 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-03-31
Date de fin
2018-09-30
Coûts totaux approuvés
CHF 395658.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%